Sign in
Stories
Biotech Collaboration Enhances CRISPR Innovations
Share
Advancements in Gene Editing and Cancer ...
Biopharma Breakthroughs and Safety Advan...
Biotech Collaboration Enhances Industry ...
4DMT Presents Positive Interim Data
Biotech Collaboration Enhances Sector So...
Biotech Collaboration for Industry Innov...
Overview
API
Modalis Therapeutics partners with Ginkgo Bioworks to leverage CRISPR technology via the Ginkgo Technology Network, targeting sectors like gene therapy and agriculture.
Ask a question
How might this partnership impact the advancements in CRISPR technology?
How will this partnership influence the competitive landscape in biotechnology?
What specific breakthroughs or products could result from this collaboration?
Article Frequency
0.2
0.4
0.6
0.8
1.0
Jan 2024
Feb 2024
Mar 2024
Coverage